Reply

The intention of LAA occlusion is stroke prevention in atrial fibrillation (AF) patients who are at high risk for ischemic stroke. [...]it seemed reasonable to determine stroke as a primary end point. In the future, once further prospective studies are completed, it may become an alternative for AF...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2006-04, Vol.47 (7), p.1500
Main Authors: Ostermayer, Stefan H, Bayard, Yves, Billinger, Kai, Trepels, Thomas, Krumsdorf, Ulrike, Sievert, Horst, Reisman, Mark, Kramer, Paul H, Matthews, Ray V, Block, Peter C, Omran, Heyder, Bartorelli, Antonio L, Della Bella, Paolo, DiMario, Carlo, Pappone, Carlo, Casale, Paul N, Gray, William A, Moses, Jeffery W, Poppas, Athena, Williams, David O, Meier, Bernhard, Skanes, Allan, Teirstein, Paul S, Lesh, Michael D, Nakai, Toshiko
Format: Article
Language:English
Subjects:
Cardiology
Drug therapy
Heart failure
Mortality
Stroke
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 7
container_start_page 1500
container_title Journal of the American College of Cardiology
container_volume 47
creator Ostermayer, Stefan H
Bayard, Yves
Billinger, Kai
Trepels, Thomas
Krumsdorf, Ulrike
Sievert, Horst
Reisman, Mark
Kramer, Paul H
Matthews, Ray V
Block, Peter C
Omran, Heyder
Bartorelli, Antonio L
Della Bella, Paolo
DiMario, Carlo
Pappone, Carlo
Casale, Paul N
Gray, William A
Moses, Jeffery W
Poppas, Athena
Williams, David O
Meier, Bernhard
Skanes, Allan
Teirstein, Paul S
Lesh, Michael D
Nakai, Toshiko
description The intention of LAA occlusion is stroke prevention in atrial fibrillation (AF) patients who are at high risk for ischemic stroke. [...]it seemed reasonable to determine stroke as a primary end point. In the future, once further prospective studies are completed, it may become an alternative for AF patients who are at increased risk for stroke and who have a contraindication for long-term anticoagulation treatment.
doi_str_mv 10.1016/j.jacc.2006.01.005
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1506168059</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3242707011</sourcerecordid><originalsourceid>FETCH-proquest_journals_15061680593</originalsourceid><addsrcrecordid>eNqNyjsKwkAURuGLGHB8bMDWesb_Gu48alGsxT6EMCmGYGLGFO7eFC7A6hTnI9ozDIPtMZlUN405AdaADSALUizidSnBLUnBlaIZwa1onXPCDD0HRcU9Dt1nS0Vbdznuft3Q4Xp5nG96GPvXFPO7Sv00PudVscCy9ZBQ_qe-PX4qTA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1506168059</pqid></control><display><type>article</type><title>Reply</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Ostermayer, Stefan H ; Bayard, Yves ; Billinger, Kai ; Trepels, Thomas ; Krumsdorf, Ulrike ; Sievert, Horst ; Reisman, Mark ; Kramer, Paul H ; Matthews, Ray V ; Block, Peter C ; Omran, Heyder ; Bartorelli, Antonio L ; Della Bella, Paolo ; DiMario, Carlo ; Pappone, Carlo ; Casale, Paul N ; Gray, William A ; Moses, Jeffery W ; Poppas, Athena ; Williams, David O ; Meier, Bernhard ; Skanes, Allan ; Teirstein, Paul S ; Lesh, Michael D ; Nakai, Toshiko</creator><creatorcontrib>Ostermayer, Stefan H ; Bayard, Yves ; Billinger, Kai ; Trepels, Thomas ; Krumsdorf, Ulrike ; Sievert, Horst ; Reisman, Mark ; Kramer, Paul H ; Matthews, Ray V ; Block, Peter C ; Omran, Heyder ; Bartorelli, Antonio L ; Della Bella, Paolo ; DiMario, Carlo ; Pappone, Carlo ; Casale, Paul N ; Gray, William A ; Moses, Jeffery W ; Poppas, Athena ; Williams, David O ; Meier, Bernhard ; Skanes, Allan ; Teirstein, Paul S ; Lesh, Michael D ; Nakai, Toshiko</creatorcontrib><description>The intention of LAA occlusion is stroke prevention in atrial fibrillation (AF) patients who are at high risk for ischemic stroke. [...]it seemed reasonable to determine stroke as a primary end point. In the future, once further prospective studies are completed, it may become an alternative for AF patients who are at increased risk for stroke and who have a contraindication for long-term anticoagulation treatment.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2006.01.005</identifier><language>eng</language><publisher>New York: Elsevier Limited</publisher><subject>Cardiology ; Drug therapy ; Heart failure ; Mortality ; Stroke</subject><ispartof>Journal of the American College of Cardiology, 2006-04, Vol.47 (7), p.1500</ispartof><rights>Copyright Elsevier Limited Apr 4, 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Ostermayer, Stefan H</creatorcontrib><creatorcontrib>Bayard, Yves</creatorcontrib><creatorcontrib>Billinger, Kai</creatorcontrib><creatorcontrib>Trepels, Thomas</creatorcontrib><creatorcontrib>Krumsdorf, Ulrike</creatorcontrib><creatorcontrib>Sievert, Horst</creatorcontrib><creatorcontrib>Reisman, Mark</creatorcontrib><creatorcontrib>Kramer, Paul H</creatorcontrib><creatorcontrib>Matthews, Ray V</creatorcontrib><creatorcontrib>Block, Peter C</creatorcontrib><creatorcontrib>Omran, Heyder</creatorcontrib><creatorcontrib>Bartorelli, Antonio L</creatorcontrib><creatorcontrib>Della Bella, Paolo</creatorcontrib><creatorcontrib>DiMario, Carlo</creatorcontrib><creatorcontrib>Pappone, Carlo</creatorcontrib><creatorcontrib>Casale, Paul N</creatorcontrib><creatorcontrib>Gray, William A</creatorcontrib><creatorcontrib>Moses, Jeffery W</creatorcontrib><creatorcontrib>Poppas, Athena</creatorcontrib><creatorcontrib>Williams, David O</creatorcontrib><creatorcontrib>Meier, Bernhard</creatorcontrib><creatorcontrib>Skanes, Allan</creatorcontrib><creatorcontrib>Teirstein, Paul S</creatorcontrib><creatorcontrib>Lesh, Michael D</creatorcontrib><creatorcontrib>Nakai, Toshiko</creatorcontrib><title>Reply</title><title>Journal of the American College of Cardiology</title><description>The intention of LAA occlusion is stroke prevention in atrial fibrillation (AF) patients who are at high risk for ischemic stroke. [...]it seemed reasonable to determine stroke as a primary end point. In the future, once further prospective studies are completed, it may become an alternative for AF patients who are at increased risk for stroke and who have a contraindication for long-term anticoagulation treatment.</description><subject>Cardiology</subject><subject>Drug therapy</subject><subject>Heart failure</subject><subject>Mortality</subject><subject>Stroke</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqNyjsKwkAURuGLGHB8bMDWesb_Gu48alGsxT6EMCmGYGLGFO7eFC7A6hTnI9ozDIPtMZlUN405AdaADSALUizidSnBLUnBlaIZwa1onXPCDD0HRcU9Dt1nS0Vbdznuft3Q4Xp5nG96GPvXFPO7Sv00PudVscCy9ZBQ_qe-PX4qTA</recordid><startdate>20060404</startdate><enddate>20060404</enddate><creator>Ostermayer, Stefan H</creator><creator>Bayard, Yves</creator><creator>Billinger, Kai</creator><creator>Trepels, Thomas</creator><creator>Krumsdorf, Ulrike</creator><creator>Sievert, Horst</creator><creator>Reisman, Mark</creator><creator>Kramer, Paul H</creator><creator>Matthews, Ray V</creator><creator>Block, Peter C</creator><creator>Omran, Heyder</creator><creator>Bartorelli, Antonio L</creator><creator>Della Bella, Paolo</creator><creator>DiMario, Carlo</creator><creator>Pappone, Carlo</creator><creator>Casale, Paul N</creator><creator>Gray, William A</creator><creator>Moses, Jeffery W</creator><creator>Poppas, Athena</creator><creator>Williams, David O</creator><creator>Meier, Bernhard</creator><creator>Skanes, Allan</creator><creator>Teirstein, Paul S</creator><creator>Lesh, Michael D</creator><creator>Nakai, Toshiko</creator><general>Elsevier Limited</general><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20060404</creationdate><title>Reply</title><author>Ostermayer, Stefan H ; Bayard, Yves ; Billinger, Kai ; Trepels, Thomas ; Krumsdorf, Ulrike ; Sievert, Horst ; Reisman, Mark ; Kramer, Paul H ; Matthews, Ray V ; Block, Peter C ; Omran, Heyder ; Bartorelli, Antonio L ; Della Bella, Paolo ; DiMario, Carlo ; Pappone, Carlo ; Casale, Paul N ; Gray, William A ; Moses, Jeffery W ; Poppas, Athena ; Williams, David O ; Meier, Bernhard ; Skanes, Allan ; Teirstein, Paul S ; Lesh, Michael D ; Nakai, Toshiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_15061680593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Cardiology</topic><topic>Drug therapy</topic><topic>Heart failure</topic><topic>Mortality</topic><topic>Stroke</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ostermayer, Stefan H</creatorcontrib><creatorcontrib>Bayard, Yves</creatorcontrib><creatorcontrib>Billinger, Kai</creatorcontrib><creatorcontrib>Trepels, Thomas</creatorcontrib><creatorcontrib>Krumsdorf, Ulrike</creatorcontrib><creatorcontrib>Sievert, Horst</creatorcontrib><creatorcontrib>Reisman, Mark</creatorcontrib><creatorcontrib>Kramer, Paul H</creatorcontrib><creatorcontrib>Matthews, Ray V</creatorcontrib><creatorcontrib>Block, Peter C</creatorcontrib><creatorcontrib>Omran, Heyder</creatorcontrib><creatorcontrib>Bartorelli, Antonio L</creatorcontrib><creatorcontrib>Della Bella, Paolo</creatorcontrib><creatorcontrib>DiMario, Carlo</creatorcontrib><creatorcontrib>Pappone, Carlo</creatorcontrib><creatorcontrib>Casale, Paul N</creatorcontrib><creatorcontrib>Gray, William A</creatorcontrib><creatorcontrib>Moses, Jeffery W</creatorcontrib><creatorcontrib>Poppas, Athena</creatorcontrib><creatorcontrib>Williams, David O</creatorcontrib><creatorcontrib>Meier, Bernhard</creatorcontrib><creatorcontrib>Skanes, Allan</creatorcontrib><creatorcontrib>Teirstein, Paul S</creatorcontrib><creatorcontrib>Lesh, Michael D</creatorcontrib><creatorcontrib>Nakai, Toshiko</creatorcontrib><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ostermayer, Stefan H</au><au>Bayard, Yves</au><au>Billinger, Kai</au><au>Trepels, Thomas</au><au>Krumsdorf, Ulrike</au><au>Sievert, Horst</au><au>Reisman, Mark</au><au>Kramer, Paul H</au><au>Matthews, Ray V</au><au>Block, Peter C</au><au>Omran, Heyder</au><au>Bartorelli, Antonio L</au><au>Della Bella, Paolo</au><au>DiMario, Carlo</au><au>Pappone, Carlo</au><au>Casale, Paul N</au><au>Gray, William A</au><au>Moses, Jeffery W</au><au>Poppas, Athena</au><au>Williams, David O</au><au>Meier, Bernhard</au><au>Skanes, Allan</au><au>Teirstein, Paul S</au><au>Lesh, Michael D</au><au>Nakai, Toshiko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reply</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2006-04-04</date><risdate>2006</risdate><volume>47</volume><issue>7</issue><spage>1500</spage><pages>1500-</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>The intention of LAA occlusion is stroke prevention in atrial fibrillation (AF) patients who are at high risk for ischemic stroke. [...]it seemed reasonable to determine stroke as a primary end point. In the future, once further prospective studies are completed, it may become an alternative for AF patients who are at increased risk for stroke and who have a contraindication for long-term anticoagulation treatment.</abstract><cop>New York</cop><pub>Elsevier Limited</pub><doi>10.1016/j.jacc.2006.01.005</doi></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2006-04, Vol.47 (7), p.1500
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_journals_1506168059
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Cardiology
Drug therapy
Heart failure
Mortality
Stroke
title Reply
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T23%3A01%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reply&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Ostermayer,%20Stefan%20H&rft.date=2006-04-04&rft.volume=47&rft.issue=7&rft.spage=1500&rft.pages=1500-&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2006.01.005&rft_dat=%3Cproquest%3E3242707011%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_15061680593%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1506168059&rft_id=info:pmid/&rfr_iscdi=true